JP2020129385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020129385A5 JP2020129385A5 JP2020075089A JP2020075089A JP2020129385A5 JP 2020129385 A5 JP2020129385 A5 JP 2020129385A5 JP 2020075089 A JP2020075089 A JP 2020075089A JP 2020075089 A JP2020075089 A JP 2020075089A JP 2020129385 A5 JP2020129385 A5 JP 2020129385A5
- Authority
- JP
- Japan
- Prior art keywords
- knowledge
- entry
- management system
- tree
- attribute description
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000013515 script Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 2
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 201000001421 hyperglycemia Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 238000012545 processing Methods 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 8
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 230000007170 pathology Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000008676 import Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 239000004020 conductor Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 2
- 208000002682 Hyperkalemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000007345 glycogen storage disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 1
- 206010004716 Binge eating Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000027790 Rib fracture Diseases 0.000 description 1
- 101710195583 Urinary protein 2 Proteins 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 208000014679 binge eating disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000021754 continuous fever Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000030133 remittent fever Diseases 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020075089A JP6868860B2 (ja) | 2020-04-21 | 2020-04-21 | 知識管理システム |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020075089A JP6868860B2 (ja) | 2020-04-21 | 2020-04-21 | 知識管理システム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017228575A Division JP6814482B2 (ja) | 2017-11-29 | 2017-11-29 | 知識管理システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020129385A JP2020129385A (ja) | 2020-08-27 |
| JP2020129385A5 true JP2020129385A5 (enExample) | 2021-02-18 |
| JP6868860B2 JP6868860B2 (ja) | 2021-05-12 |
Family
ID=72174709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020075089A Active JP6868860B2 (ja) | 2020-04-21 | 2020-04-21 | 知識管理システム |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6868860B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7769364B2 (ja) * | 2021-09-16 | 2025-11-13 | 国立大学法人山口大学 | 副作用の被疑薬推定支援装置と被疑薬推定支援プログラムと被疑薬推定支援方法 |
| JP7440966B1 (ja) | 2023-01-01 | 2024-02-29 | 優介 宮澤 | 理論構造体モデル化方法、プログラム、およびシステム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4431298B2 (ja) * | 2001-03-02 | 2010-03-10 | スマートインターネットソリューションズ株式会社 | データベース管理システム及びプログラム |
| JP5895250B2 (ja) * | 2013-06-17 | 2016-03-30 | 株式会社 デジタルコラボレーションズ | 知識管理装置、知識管理装置の端末機および知識管理装置のプログラム |
| JP2016042308A (ja) * | 2014-08-18 | 2016-03-31 | 富士通株式会社 | 情報処理装置、情報処理方法、及び情報処理プログラム |
| JP6040398B2 (ja) * | 2015-02-26 | 2016-12-07 | ヴイアールアイ株式会社 | 情報提供装置、方法およびプログラム |
-
2020
- 2020-04-21 JP JP2020075089A patent/JP6868860B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nadal et al. | Operationalizing and automating data governance | |
| JP6814482B2 (ja) | 知識管理システム | |
| US20020007373A1 (en) | System, method, and computer program product for knowledge management | |
| CN104769588B (zh) | 队列识别系统 | |
| US12468956B2 (en) | Medical document management system | |
| US20090043733A1 (en) | Systems and methods for efficiently storing, retrieving and querying data structures in a relational database system | |
| JP7083977B2 (ja) | 知識管理システム | |
| JP2021077382A5 (enExample) | ||
| JP6868860B2 (ja) | 知識管理システム | |
| Bartalesi et al. | A web application for exploring primary sources: The DanteSources case study | |
| JP2020129385A5 (enExample) | ||
| Fafalios et al. | Towards semantic interoperability in historical research: documenting research data and knowledge with synthesis | |
| Wade et al. | A Dimensional Bus model for integrating clinical and research data | |
| JP7008939B2 (ja) | 医療文書管理システム | |
| Essin et al. | Healthcare information architecture: elements of a new paradigm. | |
| Eichler | Metadata management in the data lake architecture | |
| JP2021012738A5 (enExample) | ||
| Schuler et al. | An asset management approach to continuous integration of heterogeneous biomedical data | |
| Laender et al. | Ciênciabrasil-the brazilian portal of science and technology | |
| Nadkarni et al. | Database architectures for neuroscience applications | |
| Alam et al. | A ROAD MAP FOR KILLER APPLICATIONS IN RESOURCE DESCRIPTION FRAMEWORK (RDF) AND TOPIC MAPS. | |
| Pessoal | Rodrigo Dias Arruda Senra | |
| Guo | Integrating DICOM Objects with a Database Management System | |
| Azarm | Tool Support and Data Management for Business Analytics | |
| Tekulu | Integrating semantic web technologies for Norwegian Records Management Standard Noark5: an exploratory case study |